Melissa Mercincavage1, Joshua M Smyth2, Andrew A Strasser3, Steven A Branstetter2. 1. Tobacco Center of Regulatory Science, University of Pennsylvania Philadelphia, PA. 2. Biobehavioral Health, The Pennsylvania State University, University Park, PA. 3. Tobacco Center of Regulatory Science, University of Pennsylvania, Philadelphia, PA.
Abstract
OBJECTIVES: We sought to determine if negative responses to reduced nicotine content (RNC) cigarettes during open-label trials result from smokers' (negative) expectancies. We examined the effects of nicotine content description - independent of actual nicotine content - on subjective responses (craving reduction, withdrawal suppression, mood changes, and sensory ratings) and smoking behaviors (topography measures and carbon monoxide [CO] boost). METHODS:Thirty-six 12-hour-abstinent daily smokers completed a 3-session crossover trial. During each session, participants smoked their preferred brand cigarette - blinded and described as containing "usual," "low," and "very low" nicotine content - through a topography device and completed CO and subjective response assessments. RESULTS: Although nicotine content was identical, compared to the "usual" content cigarette, participants experienced less craving reduction after smoking the "very low" nicotine cigarette, and rated its smoke as weaker (p < .05). Participants took shallower puffs of the "low" nicotine cigarette (p < .05), and rated the "low" and "very low" nicotine cigarettes as weaker and too mild (p < .01). CONCLUSIONS: Negative responses to RNC cigarettes may be due, in part, to negative expectancies about using cigarettes containing less nicotine. In this context, RNC cigarette marketing and labeling are likely important considerations if a federal nicotine reduction policy is initiated.
RCT Entities:
OBJECTIVES: We sought to determine if negative responses to reduced nicotine content (RNC) cigarettes during open-label trials result from smokers' (negative) expectancies. We examined the effects of nicotine content description - independent of actual nicotine content - on subjective responses (craving reduction, withdrawal suppression, mood changes, and sensory ratings) and smoking behaviors (topography measures and carbon monoxide [CO] boost). METHODS: Thirty-six 12-hour-abstinent daily smokers completed a 3-session crossover trial. During each session, participants smoked their preferred brand cigarette - blinded and described as containing "usual," "low," and "very low" nicotine content - through a topography device and completed CO and subjective response assessments. RESULTS: Although nicotine content was identical, compared to the "usual" content cigarette, participants experienced less craving reduction after smoking the "very low" nicotine cigarette, and rated its smoke as weaker (p < .05). Participants took shallower puffs of the "low" nicotine cigarette (p < .05), and rated the "low" and "very low" nicotine cigarettes as weaker and too mild (p < .01). CONCLUSIONS: Negative responses to RNC cigarettes may be due, in part, to negative expectancies about using cigarettes containing less nicotine. In this context, RNC cigarette marketing and labeling are likely important considerations if a federal nicotine reduction policy is initiated.
Authors: Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller Journal: Tob Control Date: 2010-10 Impact factor: 7.552
Authors: Dorothy K Hatsukami; Stephen J Heishman; Rachel Isaksson Vogel; Rachel L Denlinger; Astia N Roper-Batker; Kristen M Mackowick; Joni Jensen; Sharon E Murphy; Brian F Thomas; Eric Donny Journal: Nicotine Tob Res Date: 2012-11-22 Impact factor: 4.244
Authors: Neal L Benowitz; Katherine M Dains; Sharon M Hall; Susan Stewart; Margaret Wilson; Delia Dempsey; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-02-21 Impact factor: 4.254
Authors: Neal L Benowitz; Sharon M Hall; Susan Stewart; Margaret Wilson; Delia Dempsey; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11 Impact factor: 4.254
Authors: Dorothy K Hatsukami; Neal L Benowitz; Eric Donny; Jack Henningfield; Mitch Zeller Journal: Nicotine Tob Res Date: 2012-10-25 Impact factor: 4.244
Authors: Melissa Mercincavage; E Paul Wileyto; Megan L Saddleson; Kirsten Lochbuehler; Eric C Donny; Andrew A Strasser Journal: Addiction Date: 2017-02-23 Impact factor: 6.526
Authors: Andrea C Johnson; Melissa Mercincavage; Valentina Souprountchouk; Sasha Rogelberg; Anupreet K Sidhu; Cristine D Delnevo; Andrew A Strasser Journal: Tob Control Date: 2021-10-07 Impact factor: 7.552
Authors: Melissa Mercincavage; Joshua L Karelitz; Catherine L Kreider; Valentina Souprountchouk; Benjamin Albelda; Andrew A Strasser Journal: Drug Alcohol Depend Date: 2021-02-17 Impact factor: 4.492
Authors: Susan Veldheer; Vishal Midya; Courtney Lester; Jason Liao; Jessica Yingst; Shari Hrabovsky; Sophia I Allen; Nicolle M Krebs; Lisa Reinhart; A Eden Evins; Kimberly Horn; John Richie; Joshua Muscat; Jonathan Foulds Journal: Tob Regul Sci Date: 2018-01
Authors: Jennifer L Pearson; Mika Watanabe; Jennifer Sanchez; Suman Mann; Cara Drake; Melissa Mercincavage Journal: Nicotine Tob Res Date: 2022-01-01 Impact factor: 5.825